386
F. M. Abdelrazek, N. A. Sobhy, P. Metz, and A. A. Bazbouz
Vol 49
(3.57 g, 72% from 4a and 3.77 g, 76% from 4b), m.p.>320ꢀC.
The same compound 11 was obtained from the reaction of 1
with cyanoacetamide 4c under the same reaction conditions
(3.70 g, 75%); tmax¼ 3376, 3314, 3198 (NH), 2215 (CN),
1666 (CO) cmꢁ1; MS: m/z ¼ 496 [Mþ, 19%]; dH ¼ 2.94 (s,
2H, 2NH), 5.78 (s, 2H, pyridone 5-H), 7.11–7.57 (m, 14H,
Ar-H), 7.96 (s, 2H, 2NH). dC ¼ 81.12 (d), 95.68 (s), 116.12
(d), 117.15 (s), 126.23 (d), 127.68 (d), 128.37 (d), 134.92 (s),
136.69 (s), 140.73 (s), 163.05 (s), 169.36 (s). Anal. Calcd. for
C30H20N6O2 (496.52): C, 72.57; H, 4,06; N, 16.93. Found: C,
72.65; H, 4.22; N, 17.15.
N,N0-(1,4-Phenylene)bis(5-cyano-6-oxo-2-phenyl-6H-pyran-
3-carboxamide) 13. To a mixture of the enaminone 12 (5.1 g;
10 mmol) and ethyl cyanoacetate 4b (2.26 g; 20 mmol) in
dimethyl formamide (DMF; 25 mL) was added few drops of
sodium ethoxide as catalyst. The reaction mixture was refluxed
for 5 h and then left to cool to room temperature. The reaction
mixture was poured on ice-cold water and neutralized with
conc. HCl. The solid products thus, precipitated was collected
by filtration and crystallized from acetic acid to afford com-
pound 13 as yellow crystalline product: yield (4.21 g, 76%);
m.p. 215–216ꢀC (AcOH); tmax ¼ 3452, 3330, (NH), 2215
(CN), 1718 and 1686 (2CO) cmꢁ1; MS: m/z ¼ 554 [Mþ,
12%]; dH ¼ 7.15–7.72 (m, 14H, Ar-Hs), 8.10 (s, 2H, pyran
H), 10.05 (s, 2H, 2NH). dC ¼ 103.85 (s), 106.67 (s), 116.86
(s), 120.64 (d), 126.24 (d), 127.68 (d), 128.43 (d), 134.93 (s),
133.79 (s), 153.1 (s), 160.85 (d), 161.15 (s), 163.82 (s). Anal.
Calcd. for C32H18N4O6: (554.51): C, 69.31; H, 3.27; N, 10.10.
Found: C, 69.35; H, 3.15; N, 10.38.
6.73 (s, 2H, pyrazole H), 7.43–8.07 (m, 24H, Ar-H), 8.63
(s, 2H, Pyrimidine H), 10.22 (s, 2H, 2NH). dC ¼ 103.92 (d),
120.72 (d), 126.65 (s), 127.12 (d), 127.28 (d), 128.55
(d), 128.59 (d), 129.25 (d), 129.32 (d), 134.15 (s), 134.63 (s),
136.57 (s), 137.15 (s), 150.48 (s), 159.82 (d), 165.55 (s),
166.09 (s). Anal. Calcd for C44H30N8O2: (702.76): C, 75.20;
H, 4.30; N, 15.94. Found: C, 75.38; H, 4.50; N, 16.14.
N,N0-(1,4-Phenylene)bis(4-phenylbenzo[4,5]imidazo[1,2-a]-
pyrimidine-3-carboxamide) 18. Dark yellow crystalline prod-
uct: yield (4.62 g, 71%); m.p. 313–315ꢀC (pyridine); tmax
¼
3335, 3142 (NH), 1662 (CO) cmꢁ1; MS: m/z ¼ 650 [Mþ,
11%]; dH ¼ 7.25–8.62 (m, 22H, Ar-H), 8.64 (s, 2H, Pyrimi-
dine H), 10.20 (s, 2H, 2NH). Anal. Calcd for C40H26N8O2:
(650.69): C, 73.83; H, 4.03; N, 17.22. Found: C, 73.89; H,
4.22; N, 17.50.
(2-Phenyl (1H-benzo[b]-1,4-diazepin-3-yl))-N-{4-[(2-phe-
nyl (1H-benzo[b]-1,4-diazepin-3-yl)-carbo-nylamino-]-phenyl}-
carboxamide 20. Dirty brownish yellow crystals: yield (4.08 g,
68%); m.p. >350ꢀC (pyridine); tmax¼ 3315, 3248 (NH), 1656
(CO) cmꢁ1; MS: m/z ¼ 600 [Mþ, 15%]; dH ¼ 5.2 (s, 2H,
2NH), 6.55–7.68 (m, 24H, Ar-H), 8.20 (s, 2H, 2NH). Anal.
Calcd for C38H28N6O2: (600.67): C, 75.98; H, 4.70; N, 13.99.
Found: C, 76.05; H, 4.78; N, 14.19.
Acknowledgments. F. M. Abdelrazek thanks the Alexander von
Humboldt-Foundation (Germany) for granting a research fellow-
ship (July–August 2009) and continual support. The financial
support of this work from the research fund of the Faculty of
Science, Cairo University, is greatly appreciated.
N,N0-(1,4-Phenylene)bis(5-cyano-6-oxo-2-phenyl-1,6-dihydro-
pyridine-3-carboxamide) 14. A mixture of the bis-pyranone 13
(5.54 g; 10 mmol) and ammonium acetate (3.85 g; 50 mmol)
was fused on an oil bath adjusted at 300ꢀC for 4 h and then
left to cool overnight. The resulting mass was triturated with
acetic acid, and the lumps were crushed; then the reaction
mixture was boiled in acetic acid till complete dissolution and
filtered while hot. On leaving to cool to room temperature,
pale yellow crystals precipitated which were filtered off to
give 14; yield (3.97 g, 72%); m.p. 282–284ꢀC (AcOH). Com-
pound 14 was also prepared from 12 and cyanoacetamide 4c
in refluxing ethanol catalyzed by sodium ethoxide as described
previously [13]; Yield (3.86 g, 70%) m.p. 284–285ꢀC (AcOH);
tmax¼ 3451, 3333, 3141 (NH), 2213 (CN), 1687 (CO), and
1659 (CO) cmꢁ1; MS: m/z ¼ 552 [Mþ, 15%]; dH ¼ 7.15–7.68
(m, 14H, Ar-Hs), 7.70 (s, 2H, 2NH), 7.99 (s, 2H, Pyridone 4-
Hs), 10.07 (s, 2H, 2NH). Anal. Calcd for C32H20N6O4:
(552.54): C, 69.56; H, 3.65; N, 15.21. Found: C, 69.55; H,
3.68; N, 15.28.
REFERENCES AND NOTES
[1] Kulagowski, J. J.; Broughton, H. B.; Curtis, N. R.; Mawer,
I. M.; Ridgill, M. P.; Baker, R.; Emms, F.; Freedman, S. B.; Marwood,
R.; Patel, S.; Ragan, C. I.; Leeson, P. D. J Med Chem 1996, 39, 1941.
[2] Henry, J. R.; Rupert, K. C.; Dodd, J. H.; Turchi, I. J.;
Wadsworth, S. A.; Cavender, D. E.; Fahmy, B.; Olini, G. C.; Davis, J.
E.; Genesy, J. L. P.; Schafer, P. H.; Siekierka, J. J. J Med Chem 1998,
41, 4196.
[3] (a) Frank, H.; Heinisch, G. In Progress in Medicinal Chem-
istry; Ellis, G. P., West, G. B., Eds.; Elsevier: Amsterdam, The Neth-
erlands, 1990; Vol. 27, p 1; (b) Frank, H.; Heinisch, G. In Progress in
Medicinal Chemistry; Ellis, G. P., Luscombe, D. K., Eds.; Elsevier:
Amsterdam, The Netherlands, 1992; Vol. 29, p 141.
[4] Wang, A. X.; Qinghua, X.; Lane, B.; Mollison, K. W.;
Hsieh, G. C.; Marsh, K.; Sheets, M. P.; Luly, J. R.; Coghlan, M. J.
Bioorg Med Chem Lett 1998, 8, 2787.
[5] Mylari, B. L.; Zembrowski, W. J. US Patent 4,954,629, 1990;
Mylari, B. L.; Zembrowski, W. J. Chem Abstr 1991, 114, 62105 u.
[6] Sahin, M. F.; Badicoglu, B.; Goekce, M.; Kuepeli, E. Arch
Pharm Pharm Med Chem (Weinheim) 2004, 337, 445.
The reaction of 12 with the heteroaromatic amines 15,
17, 19. A mixture of each of the bis-enaminone 12 (5.1 g; 10
mmol) and the respective amine (aminopyrazole 15, 2-amino-
benzimidazole 17 or 1,2-phenylenediamine 19) (20 mmol) in
pyridine (25 mL) was refluxed for 5 h (TLC control). The
reaction mixture was left to cool and then was poured onto
ice-water. The solid precipitates, thus, formed were collected
by filtration and recrystallized from pyridine to afford the
products 16, 18, and 20, respectively.
[7] Betti, L.; Zanelli, M.; Gannaccini, G.; Manetti, F.; Sche-
none, S.; Strappaghetti, G. Synthesis of new pyridazine-pyridazinone
derivatives and their binding affinity toward a1,a2-adrenergic and
5-HT1A serotoninergic receptors. Bioorg Med Chem 2006, 14, 2828.
[8] Stevenson, T. M.; Crouse, B. A.; Thieu, T. V.; Gebreysus,
C.; Finkelstein, B. L.; Sethuraman, M. R.; Dubas-Cordery, C. M.; Pio-
trowski, D. L. J Heterocycl Chem 2005, 42, 427.
N,N0-(1,4-Phenylene)bis(2,7-diphenylpyrazolo[1,5-a]pyrim-
idine-6-carboxamide) 16. Yellow crystalline product: yield
(4.84 g, 69%); m.p. 293–295ꢀC (pyridine); tmax ¼ 3332, 3140
[9] Park, H-J.; Lee, K.; Park, S-J.; Ahn, B.; Lee, J-C.; Yeong,
H.; Lee, C. K-I. Bioorg Med Chem Lett 2005, 15, 3307.
[10] Watthey, J. W. H.; Stanton, J.; Peet, N. P. In Azepines, Part
2; Rosowsky, A., Ed.; Wiley: New York, 1985; pp. 1.
(NH), 1656 (CO) cmꢁ1; MS: m/z ¼ 703 [Mþ þ 1, 7%]; dH
¼
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet